Partnering to enhance bone marrow aspirate analysis with digital imaging
17 Sept 2024
Beckman Coulter Diagnostics announces an exciting expansion of its partnership with Scopio Labs, a leading medtech company specializing in AI-powered workflow solutions. Learn about the expectations and key goals of the partnership that aims to elevate hematology diagnostics by streamlining workflows, reducing diagnostic times, and enhancing test precision through digital morphology. Plus, explore the critical importance of bone marrow aspirate analysis in diagnosing hematological conditions and discover how Scopio's technology revolutionizes this traditionally labor-intensive process.
This video was filmed at ADLM 2024.
About the company
Beckman Coulter Diagnostics
Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits, service and operating-type lease payments, represents approximately 78 percent of the company s 2007 annual revenue of $2.76 billion. For more information, visit www.beckmancoulter.com.
